Financing - September 16, 2014
New owner for Diamyd Medical
Diamyd Medical is extending its collaboration with Protein Sciences regarding the development of diabetes treatment. Following the new agreement the American firm becomes one of the larger share holders of Diamyd. Diamyd Medical and Protein Sciences Corporation have announced that Protein Sciences has broadened its commitment to diabetes and become a strategic and significant shareholder […]
Clinical Trials - September 15, 2014
Diamyd tests new method
Diamyd Medical will test a new way to give Diamyd in a clinical study with five adults newly diagnosed with type 1 diabetes. Diamyd will in this study be administered directly into lymph nodes in combination with treatment with vitamin D, announces the company. The investigator initiated study has been approved by the Swedish MPA. […]
Clinical Trials - June 9, 2014
Clinical study with Diamyd Medical’s diabetes vaccine fully recruited
All participants have been included in a Phase II clinical study, DIABGAD-1, in which Diamyd Medical’s diabetes vaccine Diamyd, in a unique combination with other drugs, is tested in children and adolescents recently diagnosed with type 1 diabetes. The first results from the researcher initiated study will thereby be available in the beginning of 2015. […]
